Pages that link to "Q70120469"

The following pages link to Suppression of mouse mammary tumorigenesis by long-term tamoxifen therapy (Q70120469):

Displaying 47 items.

• Tamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancer (Q24670339) (← links)
• Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer (Q24685693) (← links)
• From Bittner to Barr: a viral, diet and hormone breast cancer aetiology hypothesis (Q24801285) (← links)
• The discovery and development of selective estrogen receptor modulators (SERMs) for clinical practice (Q26830744) (← links)
• Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial (Q28277066) (← links)
• Tamoxifen and contralateral breast cancer (Q33652861) (← links)
• Tamoxifen and estradiol improved locomotor function and increased spared tissue in rats after spinal cord injury: their antioxidant effect and role of estrogen receptor alpha (Q33715453) (← links)
• Selective oestrogen receptor modulation: molecular pharmacology for the millennium (Q33837314) (← links)
• Progress in the prevention of breast cancer: concept to reality (Q34132645) (← links)
• Tamoxifen: a most unlikely pioneering medicine (Q34180688) (← links)
• The evolution of nonsteroidal antiestrogens to become selective estrogen receptor modulators (Q34315816) (← links)
• Prevention of radiation-induced mammary tumors (Q34484842) (← links)
• Hormone-induced protection against breast cancer (Q34771456) (← links)
• Prevention of spontaneous tumours in female rats by fadrozole hydrochloride, an aromatase inhibitor (Q36081916) (← links)
• Recent advances in the treatment of breast cancer (Q36679529) (← links)
• The effects of tamoxifen treatment on the endometrium. (Q36800204) (← links)
• Tamoxifen prevents induction of hepatic neoplasia by zeranol, an estrogenic food contaminant (Q36820094) (← links)
• Exploiting the apoptotic actions of oestrogen to reverse antihormonal drug resistance in oestrogen receptor positive breast cancer patients (Q36919229) (← links)
• Short-term prophylactic tamoxifen reduces the incidence of antiestrogen-resistant/estrogen receptor-positive/progesterone receptor-negative mammary tumors (Q37363284) (← links)
• Protective effect of leuprolide acetate on 7,12-dimethylbenz(a)anthracene (DMBA)-induced mammary carcinogenesis in rats (Q38559686) (← links)
• Tamoxifen as adjuvant therapy in breast cancer. Current status (Q40385706) (← links)
• Mechanisms of action of antiestrogens (Q40471823) (← links)
• Tamoxifen modulation of etoposide cytotoxicity involves inhibition of protein kinase C activity and insulin-like growth factor II expression in brain tumor cells (Q40568816) (← links)
• What do we know and what don't we know about tamoxifen in the human uterus (Q40644013) (← links)
• Psychosocial factors in the development and progression of breast cancer. (Q40661647) (← links)
• Tamoxifen protects clonal mouse hippocampal (HT-22) cells against neurotoxins-induced cell death (Q40753470) (← links)
• Molecular mechanisms and future uses of antiestrogens (Q40892619) (← links)
• Tamoxifen induces p21WAF1 and p27KIP1 expression in estrogen receptor-negative lung cancer cells (Q40937374) (← links)
• Third annual William L. McGuire Memorial Lecture. "Studies on the estrogen receptor in breast cancer"--20 years as a target for the treatment and prevention of cancer (Q40952791) (← links)
• Sex steroids and malignancies (Q41517294) (← links)
• Experimental down-regulation of intermediate biomarkers of carcinogenesis in mouse mammary epithelial cells. (Q41530515) (← links)
• Sex steroids and malignancies (Q41692884) (← links)
• Differential effects of raloxifene, tamoxifen and fulvestrant on a murine mammary carcinoma (Q44461130) (← links)
• Involvement of PKA and Sp1 in the induction of p27(Kip1) by tamoxifen (Q44541997) (← links)
• Tamoxifen modulates protein kinase C via oxidative stress in estrogen receptor-negative breast cancer cells (Q46062825) (← links)
• A toxicity study of simultaneous administration of Tamoxifen and Diazepam to female Wistar rats (Q48732545) (← links)
• The Royal Marsden Hospital pilot tamoxifen chemoprevention trial (Q50600784) (← links)
• Anti-carcinogenic activity of Taraxacum plant. II. (Q53421438) (← links)
• Are we giving tamoxifen for too long? (Q67904672) (← links)
• Ovarian status influences the skeletal effects of tamoxifen in adult rats (Q71810652) (← links)
• An estrogen receptor genetic polymorphism and a history of spontaneous abortion--correlation in women with estrogen receptor positive breast cancer but not in women with estrogen receptor negative breast cancer or in women without cancer (Q72554049) (← links)
• The effects of intermittent progesterone upon tamoxifen inhibition of tumor growth in the 7,12-dimethylbenzanthracene rat mammary tumor model (Q72783705) (← links)
• Prevention of mammary preneoplastic transformation by naturally-occurring tumor inhibitors (Q73043576) (← links)
• Chemoprevention of breast cancer (Q73206608) (← links)
• Selective oestrogen receptor modulation: molecular pharmacology for the millennium (Q73534497) (← links)
• Induction of p21WAF1 expression via Sp1-binding sites by tamoxifen in estrogen receptor-negative lung cancer cells (Q74194228) (← links)
• Dose-dependent effect of tamoxifen therapy on endometrial pathologies in postmenopausal breast cancer patients (Q77882690) (← links)